Genesem Inc (217190) — Capital Reinvestment Ratio
Latest as of September 2025:
0.49x
Genesem Inc (217190) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩2.12 Billion) in capital expenditures (₩1.03 Billion). See 217190 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.49x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.12 Billion
KRW
Capital Expenditures
₩1.03 Billion
KRW
Data as of
Sep 2025
Most recent filing
Genesem Inc Capital Reinvestment Ratio (2014–2024)
This chart tracks Genesem Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Genesem Inc (2014–2024)
Year-by-year Capital Reinvestment Ratio for Genesem Inc from 2014 to 2024. For live market cap and broader valuation context, see Genesem Inc (217190) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | ₩10.14 Billion | ₩1.65 Billion | ▼ -32.7% |
| 2023 | 0.24x | ₩3.03 Billion | ₩731.37 Million | ▲ +890.4% |
| 2022 | 0.02x | ₩8.46 Billion | ₩206.36 Million | ▼ -86.8% |
| 2021 | 0.19x | ₩4.39 Billion | ₩812.38 Million | ▲ +121.6% |
| 2019 | 0.08x | ₩5.29 Billion | ₩442.14 Million | ▼ -95.3% |
| 2015 | 1.78x | ₩3.01 Billion | ₩5.36 Billion | ▲ +913.9% |
| 2014 | 0.18x | ₩2.77 Billion | ₩485.34 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow